Published in Dis Colon Rectum on January 01, 1997
Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol (2010) 1.24
Laparoscopic transanal abdominal transanal resection with sphincter preservation for rectal cancer in the distal 3 cm of the rectum after neoadjuvant therapy. Surg Endosc (2010) 1.06
Intersphincteric resection for very low rectal cancer: a systematic review. Surg Today (2012) 1.04
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg (2007) 1.02
Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol (2005) 0.88
Proforma-based reporting in rectal cancer. Cancer Imaging (2010) 0.87
Sphincter-sparing surgery for adenocarcinoma of the distal 3 cm of the true rectum: results after neoadjuvant therapy and minimally invasive radical surgery or local excision. Surg Endosc (2013) 0.85
Outcomes of resection for rectal cancer in India: the impact of the double stapling technique. World J Surg Oncol (2007) 0.84
Close distal margins do not increase rectal cancer recurrence after sphincter-saving surgery without neoadjuvant therapy. Int J Colorectal Dis (2012) 0.82
Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer. Surg Today (2013) 0.81
Distal clearance margin of 1 cm or less: a safe distance in lower rectum cancer surgery. Int J Colorectal Dis (2008) 0.76
Role of intraoperative frozen section for assessing distal resection margin after anterior resection. Int J Colorectal Dis (2015) 0.76
Endoscopically observable white nodule caused by distal intramural lymphatic spread of rectal cancer: a case report. World J Surg Oncol (2012) 0.75
Intramural metastasis of T1 rectal cancer: report of a case report. World J Surg Oncol (2015) 0.75
Sphincter-preserving surgery for low-middle rectal cancer: Can we predict feasibility with high-resolution magnetic resonance imaging? Medicine (Baltimore) (2017) 0.75
Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res (1986) 8.69
Cardiovascular neural regulation explored in the frequency domain. Circulation (1991) 7.49
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer (1996) 4.46
Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet (1998) 4.46
Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med (1987) 4.12
Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation (1994) 3.64
Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J (1999) 3.51
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. Ann Oncol (2008) 2.75
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med (1997) 2.73
Lack of effect of pregnancy on outcome of melanoma. For The World Health Organisation Melanoma Programme. Lancet (1991) 2.58
Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer. Cancer J Sci Am (2006) 2.42
Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial. Lancet (2001) 2.40
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer (1995) 2.28
Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg (2000) 2.27
Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med (1988) 2.15
Heart rate variability and cardiac failure. Heart (1998) 2.05
Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation (1990) 2.03
Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J (1994) 1.94
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med (2000) 1.93
Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol (2000) 1.92
First evidence of pep solar neutrinos by direct detection in Borexino. Phys Rev Lett (2012) 1.77
Nitrogen oxides from waste incineration: control by selective non-catalytic reduction. Chemosphere (2001) 1.72
Molecular basis for CD40 signaling mediated by TRAF3. Proc Natl Acad Sci U S A (2000) 1.64
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ (2010) 1.63
Results of adjuvant interferon study in WHO melanoma programme. Lancet (1994) 1.62
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Cancer Res (1996) 1.60
Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer (1991) 1.58
Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. J Clin Oncol (1996) 1.55
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors. Breast Cancer Res Treat (1999) 1.54
Liver rupture after cardiopulmonary resuscitation (CPR) and thrombolysis. Intensive Care Med (1999) 1.53
Adequacy of margins of resection in gastrectomy for cancer. Ann Surg (1982) 1.52
Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg (1983) 1.50
Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Società Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J (2001) 1.48
Autonomic indexes based on the analysis of heart rate variability: a view from the sinus node. Cardiovasc Res (2001) 1.48
Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst (1988) 1.45
Total rectal resection and complete mesorectum excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: the experience of the National Cancer Institute of Milano. Ann Surg Oncol (2000) 1.45
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience. Ann Oncol (1993) 1.37
TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem (1999) 1.35
Consideration of the fundamental mechanisms eliciting cardiac pain. Am Heart J (1982) 1.34
Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer (1981) 1.33
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials. Ann Oncol (2007) 1.29
Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res (1997) 1.29
Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol (1994) 1.28
Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg (1985) 1.27
A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet (1986) 1.27
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. Lab Invest (2001) 1.26
Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects. J Hypertens Suppl (1984) 1.25
Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol (1997) 1.24
Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst (1993) 1.23
Chaos theory, heart rate variability, and arrhythmic mortality. Circulation (2000) 1.23
Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol (2013) 1.20
Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol (1997) 1.18
A cardiocardiac sympathovagal reflex in the cat. Circ Res (1973) 1.17
Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology (2012) 1.16
Comparison between noninvasive indices of baroreceptor sensitivity and the phenylephrine method in post-myocardial infarction patients. Circulation (1998) 1.16
Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol (1998) 1.15
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. J Clin Oncol (2001) 1.15
Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem. Br J Surg (1986) 1.15
Model for the assessment of heart period and arterial pressure variability interactions and of respiration influences. Med Biol Eng Comput (1994) 1.12
Fully gapped superconductivity in a nanometre-size YBa2Cu3O(7-δ) island enhanced by a magnetic field. Nat Nanotechnol (2012) 1.11
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. Cancer Lett (2008) 1.11
Precision measurement of the (7)Be solar neutrino interaction rate in Borexino. Phys Rev Lett (2011) 1.09
Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am Heart J (1983) 1.09
Cervical cytopathology. An evaluation of its accuracy based on cytohistologic comparison. Cancer (1993) 1.09
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. J Clin Oncol (1996) 1.09
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing. J Immunol (1998) 1.08
Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer (1992) 1.07
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med (1982) 1.06
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases. Ann Hematol (2002) 1.06
Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens (1988) 1.05
The biological functions of polyamine oxidation products by amine oxidases: perspectives of clinical applications. Amino Acids (2004) 1.05
Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano. Eur J Surg Oncol (2008) 1.05
Consensus conference on laparoscopic appendectomy: development of guidelines. Colorectal Dis (2011) 1.04
Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma. Gynecol Oncol (1987) 1.03
Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. J Control Release (2007) 1.02
Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial. Tumori (1988) 1.02
Performance assessment of standard algorithms for dynamic R-T interval measurement: comparison between R-Tapex and R-T(end) approach. Med Biol Eng Comput (1998) 1.01
Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol (1986) 1.01
Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing. Am Heart J (1985) 1.01
Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas. Int J Cancer (2001) 1.00
Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol (1994) 1.00
Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J (1995) 0.99
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy. Cancer Res (1999) 0.99
Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer (1996) 0.99
Physiology and clinical implications of variability of cardiovascular parameters with focus on heart rate and blood pressure. Am J Cardiol (1994) 0.98
Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study. Virchows Arch (1999) 0.97
Conditional entropy approach for the evaluation of the coupling strength. Biol Cybern (1999) 0.97
Preoperative risk stratification in patients undergoing elective infrarenal aortic aneurysm surgery: evaluation of five risk scoring methods. Eur J Vasc Endovasc Surg (2004) 0.97
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer. Ann Oncol (2007) 0.97